Cargando…

What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?

OBJECTIVES: To examine incidence of treatment changes due to abnormal blood-test results and, to explore rates of treatment changes due to liver, kidney and haematological blood-test abnormalities in autoimmune rheumatic diseases (AIRD) treated with low-dose MTX or LEF. METHODS: Data for people with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakafero, Georgina, Grainge, Matthew J, Card, Tim, Mallen, Christian D, Zhang, Weiya, Doherty, Michael, Taal, Maarten W, Aithal, Guruprasad P, Abhishek, Abhishek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645271/ https://www.ncbi.nlm.nih.gov/pubmed/33725120 http://dx.doi.org/10.1093/rheumatology/keab254

Ejemplares similares

Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum
por: Nakafero, Georgina, et al.
Publicado: (2021)

Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink Aurum
por: Nakafero, Georgina, et al.
Publicado: (2022)

Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK
por: Nakafero, Georgina, et al.
Publicado: (2023)

Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink
por: Abhishek, Abhishek, et al.
Publicado: (2018)

Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation
por: Nakafero, Georgina, et al.
Publicado: (2023)

Do β-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink
por: Nakafero, Georgina, et al.
Publicado: (2019)

Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink
por: Nakafero, Georgina, et al.
Publicado: (2019)

Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study
por: Nakafero, Georgina, et al.
Publicado: (2018)

Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs
por: Nakafero, Georgina, et al.
Publicado: (2020)

β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score–matched cohort study
por: Nakafero, Georgina, et al.
Publicado: (2021)

Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis
por: Nakafero, Georgina, et al.
Publicado: (2022)

Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment
por: Abhishek, Abhishek, et al.
Publicado: (2022)

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)
por: Mielnik, Pawel, et al.
Publicado: (2023)

Implication of nurse intervention on engagement with urate-lowering drugs: A qualitative study of participants in a RCT of nurse led care
por: Latif, Zahira P., et al.
Publicado: (2019)

Differential effects of leflunomide and methotrexate on cytokine production in RA
por: Kraan, MC, et al.
Publicado: (2003)

Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis
por: Shashikumar, N.S., et al.
Publicado: (2010)

Comparative Effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis
por: Narváez, Javier, et al.
Publicado: (2015)

Combination of Methotrexate and Leflunomide Is Efficient and Safe for 60 Patients with Rheumatoid Arthritis
por: Chen, Fang, et al.
Publicado: (2022)

Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
por: Kuo, Chang-Fu, et al.
Publicado: (2015)

Comorbidities in patients with gout prior to and following diagnosis: case-control study
por: Kuo, Chang-Fu, et al.
Publicado: (2016)

PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis
por: Quesada-Masachs, E, et al.
Publicado: (2013)

Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis
por: Wu, Chunling, et al.
Publicado: (2020)

Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate
por: Lee, Sang-Won, et al.
Publicado: (2012)

Leflunomide/methotrexate: Visceral leishmaniasis and SARS-CoV-2 infection: case report
Publicado: (2022)

Discontinuing methotrexate to enhance vaccine response
por: Medeiros-Ribeiro, Ana C., et al.
Publicado: (2022)

Combination leflunomide and methotrexate impedes the recovery of liver fibrosis, partly through inhibition of myeloid cell admittance
por: Lin, Mengxin, et al.
Publicado: (2019)

Thrombotic microangiopathy and liver toxicity due to a combination therapy of leflunomide and methotrexate: a case report
por: Pliquett, Rainer Ullrich, et al.
Publicado: (2020)

The antecedents of biliary cancer: a primary care case–control study in the United Kingdom
por: Grainge, M J, et al.
Publicado: (2009)

IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide
por: Zhong, Wei, et al.
Publicado: (2017)

Efficacy and safety of total glucosides of paeony combined with methotrexate and leflunomide for active rheumatoid arthritis: a meta-analysis
por: Huang, Yao, et al.
Publicado: (2019)

Campylobacter Jejuni and Cytopenias
por: Schattner, Ami
Publicado: (2013)

Cytopenias in Transplant Patients
por: Barry, Maura, et al.
Publicado: (2018)

Clinical efficacy and safety of methotrexate compared with leflunomide in the treatment of rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Qi, Weiyu, et al.
Publicado: (2021)

Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020)

Chondrocalcinosis is common in the absence of knee involvement
por: Abhishek, Abhishek, et al.
Publicado: (2012)

Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients
por: Hopkins, AM, et al.
Publicado: (2015)

Cytopenia in adult brucellosis patients
por: Kaya, Safak, et al.
Publicado: (2018)

Cytopenia associated with copper deficiency
por: Uchino, Kaori, et al.
Publicado: (2021)

Traditional Chinese medicine Biqi capsule compared with leflunomide in combination with methotrexate in patients with rheumatoid arthritis: a randomized controlled trial
por: Wang, Zhang, et al.
Publicado: (2020)

Multifocal Oral Epstein–Barr Virus-Positive Mucocutaneous Ulcers Associated with Dual Methotrexate and Leflunomide Therapy: A Case Report
por: Kunmongkolwut, Sumana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rssamm4kkbhelj56hut1p4hq8s